MANAGEMENT

Christopher MH Kim, MD

Chief Medical Officer

Christopher MH Kim, MD

Christopher Kim MD has been our Chairman and CMO since our inception and the inventor and developer of Apitox in Korea and USA.

He led the clinical trials for Apitoxin in Korea, which was approved by the Korea FDA in 2003 for relief of pain and inflammation for OA. In 2005, he began focusing on the clinical development of Apitox for OA and MS in the US, including the first of two-Phase III clinical studies for Osteoarthritis. Dr. Kim has treated thousands of chronically disabled patients with autoimmune diseases with Apitox for the past 40 years.